Rubicon Genomics Garners $2,000,000 New Funding

  • Feed Type
  • Date
    7/16/2015
  • Company Name
    Rubicon Genomics
  • Mailing Address
    4355 Varsity Drive Ann Arbor, MI 48108 USA
  • Company Description
    Rubicon has developed a superior test to non-invasively diagnose cancer and other diseases using its proprietary MethylPlex technology to amplify the exceedingly small amounts of abnormally-methylated DNA that are released by diseased tissue into serum and urine.
  • Website
    http://www.rubicongenomics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Rubicon sought the new financing because it’s preparing to launch a new product called ThruPlex Plasma-seq this month.
  • M&A Terms
  • Venture Investor
    BroadOak Capital Partners
  • Venture Investor
    Research Corporation Technologies

Trending on Xconomy